Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breakthrough Pain × Fentanyl × Clear all

Phase

Phase 2 2 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 7 Colonic Neoplasms 3 Cancer Pain 3 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Agnosia 2 post laminectomy syndrome 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Pleural Effusion, Malignant 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplasms 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Ileus 1 Failed Back Surgery Syndrome 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Breakthrough Pain 1 Arrhythmias, Cardiac 1 Acute Pain 1

Interventions

Ultracet 1 Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡